Johansson P, Kutti J, Andréasson B, Safai-Kutti S, Vilén L, Wedel H, Ridell B
Haematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
J Intern Med. 2004 Aug;256(2):161-5. doi: 10.1111/j.1365-2796.2004.01357.x.
In the literature the incidence rates for the chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders (MPD) are known to vary extensively; only a few studies have, however, been concerned with incidence trends over time. Therefore, the aim of the present work was to investigate possible trends as regards incidence rates over time for Ph-MPD.
Herein, we carried out a retrospective population-based survey on the incidence of polycythaemia vera (PV), essential thrombocythaemia (ET) and chronic idiopathic myelofibrosis (IMF), in the city of Göteborg (Sweden), covering the years 1983-99.
The study comprised 416 patients with Ph-MPD. There were 205 patients with PV, 153 patients with ET, 34 with IMF and 24 with unclassified MPD. The annual incidence for PV was 1.97 per 10(5) inhabitants; the corresponding figures for ET and IMF were 1.55 per 10(5) and 0.30 per 10(5) inhabitants, respectively. There was a significant increase in the annual incidence rate for ET (P = 0.008); this increase was significant for male subjects (P = 0.015) but did not reach significance for females (P = 0.118). No such increase over time was recorded as regards PV and IMF.
The increasing annual incidence rate for ET is most possibly explained by the more frequent use of automated platelet counts whenever a patient consults a doctor. Thereby, an increasing number of patients with overt thrombocytosis of unknown origin are discovered and will be referred to specialists within the field of haematology for a correct diagnosis.
文献中已知慢性费城染色体阴性(Ph-)骨髓增殖性疾病(MPD)的发病率差异很大;然而,仅有少数研究关注其发病率随时间的变化趋势。因此,本研究的目的是调查Ph-MPD发病率随时间的可能变化趋势。
在此,我们对瑞典哥德堡市1983 - 1999年真性红细胞增多症(PV)、原发性血小板增多症(ET)和慢性特发性骨髓纤维化(IMF)的发病率进行了一项基于人群的回顾性调查。
该研究包括416例Ph-MPD患者。其中有205例PV患者,153例ET患者,34例IMF患者和24例未分类的MPD患者。PV的年发病率为每10^5居民中1.97例;ET和IMF的相应数字分别为每10^5居民中1.55例和0.30例。ET的年发病率有显著增加(P = 0.008);这种增加在男性受试者中显著(P = 0.015),但在女性中未达到显著水平(P = 0.118)。未记录到PV和IMF随时间有此类增加。
ET年发病率的增加很可能是由于患者就医时自动血小板计数的使用更为频繁。由此,发现了越来越多不明原因的明显血小板增多症患者,并将被转诊至血液学领域的专家处进行正确诊断。